1. Pathogenic hypothalamic extracellular matrix promotes metabolic disease.
- Author
-
Beddows CA, Shi F, Horton AL, Dalal S, Zhang P, Ling CC, Yong VW, Loh K, Cho E, Karagiannis C, Rose AJ, Montgomery MK, Gregorevic P, Watt MJ, Packer NH, Parker BL, Brown RM, Moh ESX, and Dodd GT
- Subjects
- Animals, Male, Mice, Rats, Insulin metabolism, Mice, Inbred C57BL, Mice, Obese, Neurons metabolism, Neurons pathology, Obesity metabolism, Obesity pathology, Obesity therapy, Rats, Sprague-Dawley, Arcuate Nucleus of Hypothalamus drug effects, Arcuate Nucleus of Hypothalamus metabolism, Arcuate Nucleus of Hypothalamus pathology, Chondroitin Sulfate Proteoglycans metabolism, Extracellular Matrix drug effects, Extracellular Matrix metabolism, Extracellular Matrix pathology, Insulin Resistance, Metabolic Diseases metabolism, Metabolic Diseases pathology, Metabolic Diseases therapy
- Abstract
Metabolic diseases such as obesity and type 2 diabetes are marked by insulin resistance
1,2 . Cells within the arcuate nucleus of the hypothalamus (ARC), which are crucial for regulating metabolism, become insulin resistant during the progression of metabolic disease3-8 , but these mechanisms are not fully understood. Here we investigated the role of a specialized chondroitin sulfate proteoglycan extracellular matrix, termed a perineuronal net, which surrounds ARC neurons. In metabolic disease, the perineuronal net of the ARC becomes augmented and remodelled, driving insulin resistance and metabolic dysfunction. Disruption of the perineuronal net in obese mice, either enzymatically or with small molecules, improves insulin access to the brain, reversing neuronal insulin resistance and enhancing metabolic health. Our findings identify ARC extracellular matrix remodelling as a fundamental mechanism driving metabolic diseases., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF